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 Generalized progressive retinal atrophies (gPRAs) in do-
mestic dogs (Canis familiaris) are a group of inherited retinal
dystrophies that share a similar phenotype. gPRA causes pro-
gressive loss of vision, usually leading to blindness. Initially
rod photoreceptor vision is affected, causing night blindness
followed by progressive loss of cone photoreceptors with de-
teriorations in daytime vision. gPRAs can be classified by age
of onset and rate of progression [1]. Certain breeds show early
onset forms, e.g. Collies, Irish Setters, Norwegian Elkhounds
and Miniature Schnauzers. In these breeds, the disease results
from abnormal or arrested development of the photoreceptor
cells in the retina, and gPRA affects pups very early in life. In
other breeds (including Miniature Poodles, English and Ameri-
can Cocker Spaniels, Labrador Retrievers) gPRA onset oc-
curs much later. Affected dogs in these latter breeds appear
normal when young, but develop gPRA as adults.
Two X-linked [2] and an autosomal dominantly inherited
trait [3,4] have been described, yet most gPRA forms are trans-
mitted in an autosomal recessive (AR) mode. Up to now, caus-
ative mutations have been identified only in few breeds of
dogs with AR transmitted gPRA [5-11].
In addition to the respective pedigree material highly in-
formative polymorphic DNA markers [12,13] are the neces-
sary tools for mapping chromosomal locations of disease gene
loci by linkage analysis. In order to determine the molecular
basis of canine gPRA, we initiated whole-genome scanning
(WGS) using markers spread evenly across the canine genome
for linkage in gPRA-informative pedigrees of the Schapendoes
breed. Here we demonstrate linkage of the gPRA trait to mark-
ers on canine chromosome 20 (CFA20) in Schapendoes. In
addition, the critical region was fine mapped, and the novel
candidate genes CACNA2D3, HT017, and WNT5A were in-
vestigated.
METHODS
Animals:  All dogs were collected from the general breeding
population of pure-bred Schapendoes. Five pedigrees, com-
prising 57 Schapendoes dogs including 13 gPRA-affected
animals, were available in which gPRA is transmitted in an
AR manner. Ophthalmologically experienced veterinarians
confirmed the gPRA status of affected and unaffected dogs by
ophthalmoscopy as documented in certificates of eye exami-
nations. gPRA in Schapendoes is characterized by late onset
and slow progression as documented by veterinarians of the
Dortmunder Ophthalmologenkreis (DOK). Affected
Schapendoes dogs appear normal when young, but develop
gPRA at an age of onset between 2-5 years. Early in the dis-
ease, affected dogs are night-blind, lacking the ability to ad-
just their vision to dim light; later, their daytime vision also
fails. This process of complete photoreceptor degeneration
takes up to 2 years.
Genomic DNA was extracted from peripheral blood ac-
cording to standard protocols [14]. For isolation of RNA and
retina sections we obtained an eye of a gPRA-affected, five
year-old Schapendoes with complete loss of night vision yet
anecdotally remaining, very limited day-time vision. Retinas
of gPRA-free Saarloos/Wolfshounds were used as controls.
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174Histology:  The enucleated eyes from a five year old,
gPRA-affected Schapendoes dog and control eyes from a
gPRA-free Sarloos/Wolfshound were sagittally cut at the level
of the optic nerve, immersion-fixed in 100% ethanol and par-
affin-embedded. Serial sections, 15 µm thick, were cut over
the whole extension of the retina, stained with hematoxylin
and eosin and photo-documented.
Markers and genotyping:  For the WGS highly informa-
tive autosomal microsatellite markers were analyzed from the
minimal screening set 2 (MSS-2) [12]. Microsatellites for fine
mapping (Table 1, Figure 1) were identified using published
dog markers [15], the dog genome sequence (May 2005) and
the Tandem Repeats Finder included in the UCSC Genome
Browser. Only microsatellites with a repeat length exceeding
15 units were selected. PCR primers were designed using
Primer Express software (PE Biosystems). For PCR we used
the “tailed primer PCR” as described before [16]. This method
requires three oligonucleotides for amplification: 1. tailed for-
ward primer (tailed F), 2. reverse primer and 3. labeled primer
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Figure 1. Haplotypes of the gPRA Schapendoes families SD1-5 as established by microsatellite markers for chromosome 20.  Affected dogs
are represented by black, unaffected by white and those with known carrier status are represented by half-filled symbols. Circles represent
females and squares represent males. Genotype that could not be ascertained are scored as “0”. Black bars indicate the affected haplotype. In
the box, genotyped markers and the disease haplotype are indicated. The observed recombination events evidence the disease causing locus in
the region between markers FH3358 and TL195IIMS.
TABLE 1. MICROSATELLITE MARKERS FOR MAPPING, PRIMERS FOR
PCR AMPLIFICATION, THEIR LOCATION AND PCR PRODUCTS SIZES
             Microsat                                  Location    Size
  Marker       type       Primer sequence (5'-3')      on CFA20    (bp)
----------   --------   ---------------------------   ----------   ----
REN100J131   di         TGATTGACTCTACTTTACACA         25,817,177   164
                        TATATTAGGCGGTTTTCTTCT         25,817,034
FH33582      tetra      CATCACCCAAATTCAAAGGCA         33,096,985   268
                        CCATCAAGGCCCTAATATTTAAAGATT   33,097,252
REN149D232   di         GACAGAAGAGCCCATCGAG           37,609,209   168
                        CATAGTCACACCCACCAATG          37,609,376
REN316E232   di         AAAAAGAGGATGGGATGGAG          38,133,160   154
                        TCAGATAGATCATTTGCTGCC         38,133,313
TL335MS      di         CCCCATAGAAAAGGGACTG           38,313,482   126
                        CACTTTCTCTCCCCCTCTG           38,313,607
REN93E071    di         GGCCCCCTCACCACTCC             38,525,708   170
                        TGAGGGCTGCCACTGTAAATA         38,525,877
TL336MS      di         TCACTGGTACAGGCATTGTTC         38,727,171   133
                        CCTTATGTCCATCCCCATC           38,727,303
TL337MS      di         AAGGCTACTTTTGGGACCC           38,956,429   335
                        TGAGAGGTGAGAGATGCTGG          38,956,763
TL327MS      di         TGGCTTGTTATGAAGTTGGCC         39,812,660   167
                        AGCCCCAGGTGCTATGGAG           39,812,826
TL195II      di         AACTGAGGTTCCCTTGTTCC          47,049,704   232
                        CTAATCGAAAGTGCAGGAGG          47,049,935
REN114M191   di         CCATACAGCCACACCAAGTG          56,553,756   192
                        GCTCCCTGACCACAGGTCT           56,553,948
Location ascertained from UCSC Genome Browser (assembly: dog
May 2005).
175(labeled F) corresponding to the 5'-tail sequence of tailed F.
PCR conditions were as follows: 1-PCR buffer (Genecraft,
Lüdinghausen, Germany), 0.2 mM each dNTP, 1.5 to 3 mM
MgCl2, 0.2 pmol tailed F, 2.5 pmol labeled F, 2.5 pmol reverse
primer, 0.5 U BioTherm DNA Polymerase (Genecraft) and 50
ng DNA. PCRs were performed in 96-well microtiter plates
(Thermowell Costar Corning, NY). Each well contained a re-
action volume of 10 µl. A “touchdown” PCR procedure was
applied in a thermocycler (Biometra, Göttingen, Germany):
initial denaturation (5 min at 95 °C), two initial cycles 6 °C
and 3 °C above the annealing temperature, 40 cycles of 95 °C
(30 s), annealing temperature of 53 °C (30 s), elongation at 72
°C (30 s) and a final elongation step at 72 °C (3 min).
Electrophoreses were run using Amersham Biosciences
standard protocols for genotyping on the automated capillary
DNA sequencer (MegaBACE 1000, Amersham Biosciences,
Freiburg, Germany). PCR products of two markers were di-
luted (each 1:10), pooled and 2 µl of this dilution were mixed
with 0.5 µl of MegaBACETM ET-R Size Standard and 2.5 µl
loading solution (70% formamide, 1 mM EDTA). Raw data
were analyzed by the MegaBACE Fragment Profiler software
version 1.2 (Amersham Biosciences, Freiburg, Germany) and
a table of genotypes was exported. For a few markers no PCR
products were obtained for specific dogs.
Linkage analyses:  Using the LINKAGE package ver-
sion 5.1 [17], we undertook two-point linkage analyses be-
tween the gPRA locus and each marker. The disease trait was
coded as being AR transmitted with full penetrance, no phe-
nocopy and a frequency of 0.1 for the disease allele. The data
were controlled for Mendelian inheritance using the unknown
program, and two-point linkage analyses were performed us-
ing mlink program [17]. Marker-allele frequencies were cal-
culated on the basis of genotype data of 10 unrelated indi-
viduals of the schapendoes breed.
Mutation screening of candidate genes CACNA2D3,
HT017, and WNT5A: Exon/ intron boundaries of the canine
genes CACNA2D3, HT017, and WNT5A were searched for by
comparison of the mRNA sequence of the human gene (ac-
cession numbers: CACNA2D3, NM_018398;HT017,
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TABLE 2. PRIMERS FOR AMPLIFICATION OF EXONIC REGIONS OF
CACNA2D3, HT017, AND WNT5A INCLUDING EXON/INTRON
BOUNDARIES
                                                       Size
  Gene      Exon          Sequence (5'-3')             (bp)
--------   ------   --------------------------------   ----
CACNA2D3   1F       GGTGCTGGCAGTTTCTACCC               268
           1R       ATCGCTTCCTGCCACCAC
           2F       AAGAGAGGCAGTCCTATTTATTCCTTG        329
           2R       GAACAACTGAGTCAACTTCACTCTTTG
           3F       AAGGCTCCAGGTCATAATGCAC             261
           3R       CTTACCATTTCTTGTTTGGCAGC
           4F       GACACCCTTACCTGGCTTTGC              355
           4R       TGTCCCCCATACCCTCTGTTC
           5F       CTCATGCTGCTATTGCCAGC               326
           5R       TCATTTTCCCCTATTGGGAGG
           6+7F     CAGGGCTGGTCATTGCATG                546
           6+7R     AGGCGGGACATCTAATGCTG
           8F       GGTACCCCTCAAATGATTAATTGTG          201
           8R       TAGGTTTGTATCATGACCCTTGATG
           9F       CCATTCCAGTCTGAGACTCGTTG            311
           9R       GCCAAGGCTAACCATAATGCTG
           10F      GGGAAATGCTTATCGTGTAGGTTC           422
           10R      AGAGCCATAGTATTCGGTTTGGTC
           11F      CCTACAGATGGGAAGCCTGG               277
           11R      CTCTTAACTATCCCAACTTGCGC
           12F      TGAGAGGTGGGTTTATGGTTGAC            394
           12R      GGTTAACACGGTCTTCTGGAATTAAC
           13F      TTGCCAGTGGTGACCAAATG               208
           13R      GTACTGAATGCACAAAATCATGGAG
           14F      ACTGGTCTGTTCCCAATGGC               266
           14R      CACCAGAGCTTGAGTCAGAGAATG
           15F      AAACTTTGAGAAGGCACCAGATG            248
           15R      AGGTATCTTGGACGCTTAGTCCTG
           16F      TGAATTCACCAGGGAGCCAG               221
           16R      AAACGCTGCTGCAAAAGTGTC
           17F      GCTTCTCTCCAATATCCCTCCAC            279
           17R      TGGCCTCCAGGTACAGAACTG
           18+19F   AGCATGCTGACTTGGTGCC                693
           18+19R   CACTCTTTCCAGCCTTTTGGC
           20F      AAACCAACACCAACTATAATCAGTGG         310
           20R      TCTTTCATTAATCCAATGACTGGC
           21+22F   GGGAGATGCAAGTGAGGAGG               637
           21+22R   GCTGGATTTGATGGGACCG
           23F      AGAACTGTTCCATATTTTCAGCTGG          406
           23R      TCGAGCTCTTGTGGTTTGGAG
           24F      TTGCATTCTGTGCTTGGTGC               359
           24R      ATCAAGAAACGCAAGCCTCC
           25F      TCTCCACACTTTCGCCAACAC              484
           25R      GGCCAATATTCAACACTGCCTC
           26F      CACAGCAGCTATGGCGTCAC               410
           26R      ACCAGCTGTCAGAATCTTGAATTG
           27F      TGCTTGCATCAGCTTCTTGC               251
           27R      GCACTTTTAGGCTCCGGGTAC
           28F      TAAGTGGCAATCATAGCAGATGC            232
           28R      TCAGGAGCAATCTGTCAGACAAG
           29F      CCATGGCCTTAACTCCTAGAGC             381
           29R      GGCTGTGACATTTTTAGAGGGATAG
           30F      TCCTGATTCTTCTCTGGTGCTTG            231
           30R      GGCTTGCTTTATTTGACCTTGG
           31F      GACTTTGCATGTTCCTGGTTTG             304
           31R      CACAGATAAAGATATGCTCACGCTC
           32F      GGTATCCAACCATGTTCTTCTTGTAG         373
           32R      TGGTCTCAGCTTTCAATATTTCGAG
           33F      GGGTAACACAACCAACCATACTGTAC         290
           33R      TGTATGTTTGTCCATCCTTGGTG
           34F      GAGCGGAACTGGGTTCTGAG               352
           34R      TCTAGCGAAGCCAAATGATGC
           35+36F   GGGAGTTTTCCTCAGGATCTTTG            551
           35+36R   ATGAGACTCTCATGGTGAATCTGG
           37F      AAGACTTGATTCCTACTTTGGAGAGC         630
           37R      AAGTCTCTGCCAACAACCATCC
HT017      1F       GCGTTGAAGAAAAGCACAAGC              209
           1R       AGTCCCTTCCTCCCACGG
           2aF      ATTCCTTGTGACTTCAGAGGGAC            487
           2aR      GGAGCTTGATTTGTCATCAAACA
           2bF      GCAGACTTTTCCACTCCCTCC              319
           2bR      CCTGCGTGTTACCAGCCTAGT
           3F       GCTGTATATATTCCATCTGCCTGAG          605
           3R       GTGAATGCATCAACCCTACTCATATAC
WNT5A      1F       GTAAAGTCTTTTGCACAATCACGC           468
           1R       AAAAAGTGGCGAGCGTCG
           2F       AACTCAACGGAGGAGAAGCG               302
           2R       AATAAAACAAAGCATATGTACTTAGAAGGAAC
           3F       ACTTTGTCATGAGGACAAGCAGG            440
           3R       TCTTCAGGAGAACACTTGATCCG
           4F       GGGTCAGAGTGGAGACGCC                503
           4R       TTGTCAGGCAGCATCAGGC
           5F       GGAGCGGAGCTTTGGTAACC               599
           5R       AAATAAGTGGGTCCTGGGAGC
The intronic primer sequence for amplification of corresponding ex-
ons and 50 intronic bases on either end of the exons and the product
sizes are shown.
TABLE 3. PRIMERS FOR AMPLIFICATION OF CACNA2D3 CDNA
                                                 Size
    Primer              Sequence (5'-3')         (bp)
---------------   ----------------------------   ----
CACNA2D3 Ex2 F    ATGGAAGAGATGTTTCACAAAAAGTC     605
CACNA2D3 Ex7 R    GCAATAATGTTGAAAAAGTCATCATCC
CACNA2D3 Ex6 F    ATTAAATGGGAACCAGATGAGAATG      375
CACNA2D3 Ex9 R    ATCACTGAGAATGTTGAAGGCC
CACNA2D3 Ex9 F    CACTTCAGGGAGCATCTGGAC          728
CACNA2D3 Ex17 R   CACTCCACCTCAGAGAGGTCAAC
CACNA2D3 Ex15 F   AGATCGAAAGGCATTCTTCTGG         624
CACNA2D3 Ex23 R   GGCATCAAAGAGGACTTCTTGTATC
CACNA2D3 Ex20 F   AGGTGTGGCGCTCTCCAG             752
CACNA2D3 Ex29 R   CCAGAATAAACCCATTATTGTCTATGAG
CACNA2D3 Ex28 F   GCCTCTCTGGATGGCAAATG           762
CACNA2D3 Ex37 R   TCACCTTGAGAAGAGCATTAAGAGC
The exonic primer sequences for amplification of overlapping poly-
merase chain reaction products of the cDNA and the product sizes
are shown.
176NP_065729;WNT5A, NM_003392) with the publicly avail-
able dog genome sequences in UCSC Genome Browser (as-
sembly: dog May 2005). For sequencing of the coding regions
of the three genes, intronic PCR primers flanking the exons
were designed in order to amplify at least 50 intronic bases on
either end of the exon in order to cover the splice junctions
(Table 2). PCRs were performed under standard PCR condi-
tions [18] with BioTherm DNA Polymerase (Genecraft) and
1.5 mM MgCl2 at an annealing temperature of 57 °C.
For sequencing of the CACNA2D3 cDNA total RNA of
retinal tissue was isolated. For this purpose peqGOLD TriFast
reagent (Peqlab, Erlangen, Germany) was added to the frozen
tissue samples, the mixture was immediately homogenized and
total RNA was then extracted using guanidinium
isothiocyanate (RNeasy Mini Kit, Qiagen, Hilden, Germany).
cDNA was synthesized by oligo-dT priming with the
Sensiscript RT Kit (Qiagen, Hilden, Germany). Overlapping
PCR products of the cDNA of the CACNA2D3 gene were gen-
erated using the primers in Table 3.
All sequencing reactions were carried out by the dideoxy
chain termination method using the Dyenamic ET Terminator
Kit (Amersham Biosciences, Freiburg, Germany) according
to the manufacturer’s instructions. Reaction products were run
on an automated capillary DNA sequencer (MegaBACE 1000,
Amersham Biosciences, Freiburg, Germany).
Quantitative real-time RT-PCR of candidate gene
CACNA2D3: Total RNAs from the retinae of a gPRA-affected
Schapendoes and an unaffected Saarloos/Wolfshound were
subjected to quantitative real-time RT-PCR analysis using the
QuantiTect SYBR Green assay (Qiagen, Hilden, Germany) as
described by the manufacturer and the iCycler iQ real-time
PCR detection system (Bio-Rad, München, Germany). PCR
primers were designed using Primer Express software (PE
Biosystems). In order to avoid amplification of contaminat-
ing genomic DNA, the primers span an intron. CACNA2D3
mRNA/cDNA was amplified using primers CACNA2D3 Ex9-
F (5'-CAC TTC AGG GAG CAT CTG GAC-3') and
CACNA2D3 Ex10-R (5'-GGC TGC AGA TGC TTC CTTG-
3'). ATP-binding cassette, sub-family A, member 4 gene
(ABCA4) and guanine nucleotide binding protein, α transduc-
ing activity gene (GNAT1) are retina specific. They were am-
plified using primers ABCA4-F (5'-TGG AGG AAA GCT
CCC AAT CC-3') and ABCA4-R (5'-GCC TCT CTG GTG
ATA GGG CC-3') and GNAT1-F (5'-GCT CGC GTG TCA
AGA CCA C-3') and GNAT1-R (5'-ATC CAC TTC TTG CGC
TCT GAG-3'). Hypoxanthin phosphoribosyltransferase 1
(HPRT1) served as internal reference and was amplified us-
ing primers HPRT1-F (5'-AGC TTG CTG GTG AAA AGG
AC-3') and HPRT1-R (5'-TTA TAG TCA AGG GCA TAT CC-
3'). One-step PCR cycling was carried out by reverse tran-
scription at 50 °C for 30 min, initial activation step at 95 °C
for 15 min x1 cycle, 4-step cycling at 94 °C for 15 s, at 60 °C
for 30 s, at 72 °C for 30 s x 40 cycles. As soon as the PCR was
completed, baseline and threshold values were set automati-
cally and threshold cycle (CT) values were calculated. CT
values were exported to Microsoft Excel for calculating the
real copy number. The CT value represents the PCR cycle at
which an increase in fluorescence can first be detected above
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Figure 2. Hematoxylin-, eosin-stained paraffin sections illustrating normal canine retina and gPRA-affected retina of a Schapendoes dog.  A:
The retina of a Saarloos/Wolfshound exhibited regular nuclear layers with the nerve fiber layer (NF), ganglion cell layer (GCL), inner plexi-
form layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL), photoreceptor layer (RCL), and the
pigment epithelium (PE). B: In the degenerated retina of a Schapendoes dog the outer retina with the RCL and ONL was missing, the INL and
the IPL reduced, the GCL was comparatively preserved. CH represents choroid. The scale bar in B represents 20 µm; same magnification for
A and B.
177a base line signal level. Signals were quantified by normaliz-
ing with GAPDH expression.
RESULTS
 Compared to a normal retina (Figure 2A), the gPRA-affected
eyes of a five year old Schapendoes displayed typical degen-
eration signs in peripheral and central areas (Figure 2B). The
outer retina with the photoreceptor layer and the outer nuclear
layer was missing in all retinal parts investigated. The inner
retina showed reduced inner nuclear and inner plexiform lay-
ers, whereas the ganglion cell layer appeared comparatively
preserved.
A detailed ophthalmological examination was performed
on all 57 Schapendoes of five different families revealing 13
dogs with bilateral affection. Evaluation of gPRA in these five
families suggested that the disease segregates as an AR trait
(Figure 1). A case of inbreeding was identified in family SD3.
Initially, WGS for linkage was performed in the five pedi-
grees using markers of the MSS-2 [12]. Having completed
the typing of 165 microsatellites (CFA1-20 and 24-26) of 325
MSS-2 markers, the WGS was abbreviated after a two-point
lod score of 4.78 at q=0.000 was obtained for marker
REN93E07. The high lod score indicated that the gPRA phe-
notype was linked to a mutation on CFA20. For fine mapping
of the gPRA region in the Schapendoes breed nine additional
microsatellite markers from CFA20 were genotyped between
marker REN100J13 and TL195IIMS (Table 1, Figure 1) in
the five pedigrees. With one exception all microsatellites rep-
resent dinucleotide repeats. Heterozygosity values range
around 0.5, and 4-10 different alleles were analyzed in the
Schapendoes population. Two-point lod scores for linkage
between the gPRA locus and microsatellite markers gave still
a maximum lod score of 4.78 with marker REN93E07.
Genotyping of ten microsatellite markers for all 57 dogs
of the five pedigrees revealed that the “2-2-3-2-2-2-2” haplo-
type (marker REN149D23 to TL327MS) segregates with the
gPRA trait and has a frequency of 50% in the analyzed pedi-
grees (Figure 1). Analysis of this haplotype placed the gPRA
locus in a region between marker FH3358 and TL195IIMS. A
potential double recombination event in the dog SD90 of family
SD5 may be interpreted to confine the size of the critical hap-
lotype to 5.6 Mb flanked by markers FH3358 and TL336MS.
©2007 Molecular Vision Molecular Vision 2007; 13:174-80 <http://www.molvis.org/molvis/v13/a20/>
Figure 3. Schematic overview of the critical region on chromosome
20 in which the gPRA locus maps in Schapedoes dogs.  On the left
hand side of the chromosome the analyzed genes and their genomic
location are shown, on the right hand side genotyped microsatellite
markers are depicted. Location ascertained from UCSC Genome
Browser (assembly: dog May 2005).
Figure 4. Analysis of gene expression by quantitative real-time re-
verse transcriptase polymerase chain reaction.  Real-time RT-PCR
was used to determine the expression of the genes CACNA2D3,
GNAT1, and ABCA4 by calculating the real copy number. Expres-
sion levels were normalized to those of the HPRT1 gene. No differ-
ences were obvious between the unaffected Saarloos/Wolfshound (Sa;
N=2) and the g-PRA affected Schapendoes (SD; N=1) for CACNA2D3
mRNA. GNAT1 and ABCA4 mRNA expression is substantially re-
duced or absent in retinal tissue of the affected Schapendoes.
178For the “recombined region” of dog SD90 no canine gene has
been published in the different gene banks so far. Comparison
of the canine DNA sequence of the critical region with the
human genome in UCSC Genome Browser (assembly: hu-
man May 2004) shows homology with chromosome 3p. In
man this region comprises candidate genes for retinitis
pigmentosa (RP)-and thus also for gPRA in Schapendoes. The
marker with the peak lod score REN93E07 is located in in-
tron 7 of candidate gene CACNA2D3 (Figure 3) which spans
a genomic region of about 830 kb (kb) and consists of 37 ex-
ons. The mRNA of this gene encodes the calcium channel α2δ3
subunit, which is mainly expressed in brain [19] and also in
the eye UniGene. In intron 26 of the human CACNA2D3 gene
the HT017/LRTM1 gene is located (Figure 3). This gene en-
codes the leucine-rich repeat and transmembrane domain 1.
Upstream of CACNA2D3 the WNT5A gene is situated (Figure
3) encoding member 5A of the wingless-type MMTV integra-
tion site family. Sequencing of the candidate genes HT017
and WNT5A did not reveal any pathogenic mutations, neither
in the coding sequences nor in intron/exon junctions of af-
fected individuals. Five single nucleotide polymorphisms
(SNPs) were detected in the CACNA2D3 gene: IVS16-7T>C,
IVS23-51A>T, IVS29+18A>G, IVS29+57C>T, IVS30-
57T>C. Yet, these SNPs occur in homozygous state not only
in gPRA-affected dogs, but also in healthy Schapendoes (data
not shown). Thus these SNPs do not cause gPRA in
Schapendoes. Additionally, a thymin-insertion in intron 6
(IVS6-38_-34insT) was identified in comparison to the UCSC
dog genome sequence (assembly: dog May 2005). Further in-
vestigations revealed that this insertion was present in homozy-
gous state in healthy dogs of other breeds, implying a non-
pathogenic polymorphism. Furthermore, sequencing of the
CACNA2D3 cDNA from a diseased Schapendoes eye revealed
no sequence deviations, thus excluding “hidden” mutations
affecting the splicing process. In addition, altogether 25 kb in
introns 5, 7 and 8 of the CACNA2D3 gene comprising evolu-
tionarily conserved sequences were analyzed without any hint
on the gPRA mutation in question (data not shown).
In order to exclude potential transcriptional impact of the
elusive gPRA mutation, the expression of CACNA2D3 mRNA
in retinal tissue was determined by real-time RT-PCR (nor-
malized to the level of the housekeeping gene HPRT). mRNA
expression of two unaffected Saarloos/Wolfshounds was com-
pared to a gPRA-affected Schapendoes. GNAT1 and ABCA4
gene expression was substantially reduced in retinal tissue of
the affected Schapendoes. In contrast, no reduction was obvi-
ous for the CACNA2D3 mRNA levels (Figure 4).
DISCUSSION
 The responsible locus for gPRA in Schapendoes, a canine
counterpart for RP in man, maps to the central region of CFA20.
Haplotype analyses defined the critical interval between marker
FH3358 and TL195IIMS. The haplotype potentially confin-
ing a smaller critical interval (between FH3358 and TL336MS)
occurred exclusively in individual SD90 of family 5. A caveat
remains to accept this confinement: Alleles 3 for markers
TL336MS and TL337MS might not represent a recent or an-
cestral recombination event, but rather be due to non-mendelian
inheritance. Yet non-mendelian inheritance appears less likely
for two adjacent microsatellites in the absence of any addi-
tional slippage mutations of these microsatellites in all the other
analyzed meiotic events. Consequently, we concentrated ini-
tially on the smaller critical interval between FH3358 and
TL336MS, albeit the genomic region between TL337MS and
TL195IIMS must not be excluded formally to comprise addi-
tional candidate genes.
An interesting candidate in the critical genomic interval
represents the CACNA2D3 gene. The marker with the highest
lod score REN93E07 was located in intron 7. Direct sequenc-
ing of all coding exons for homozygously affected and nor-
mal SD dogs exclude a gPRA-causing mutation in the coding
sequence of the CACNA2D3 gene. This fact implies that the
mutation causing gPRA in Schapendoes may be located
intronically in the CACNA2D3 gene affecting splicing. Yet,
extensive sequence analysis of retinal cDNA revealed no splice
mutation in the CACNA2D3 gene. Furthermore, in order to
exclude the CACNA2D3 gene as causative for gPRA in
Schapendoes, we analyzed the expression of CACNA2D3
mRNA in retinal tissue: mRNA levels were nearly identical
between a gPRA-affected Schapendoes and an unaffected
Saarloos/Wolfshound. In contrast, the expression of the retina-
specific genes GNAT1 and ABCA4 appeared reduced substan-
tially or even absent. Photoreceptor cells in the retina of the
affected Schapendoes have vanished so that an expression of
retina-specific genes cannot be demonstrated. Since its mRNA
expression is unaltered in a retina without photoreceptor cells,
the CACNA2D3 gene appears expressed mainly in the cell
types not affected by gPRA. Yet also photoreceptor cells may
well produce small but crucial amounts of CACNA2D3 tran-
scripts that do not significantly affect the mRNA levels from
unseparated retinal extractions. Given the availability of re-
spective tissue samples, we could nevertheless use the haplo-
type-defined linkage region data to examine obligatorily ho-
mozygotic mutation carriers for altered retinal mRNA expres-
sion already presymptomatically.
Since gPRA in Schapendoes is probably not caused by a
CACNA2D3 mutation, mutation analysis of the HT017 and
WNT5A genes were performed. Yet, gPRA-causing mutations
were excluded in the coding sequence of these two genes. In
comparison to the UCSC dog genome sequence (assembly:
dog May 2005) the critical region between marker FH3358
and TL336MS comprises further candidate genes, which are
be investigated. In case the causative mutation is not identi-
fied in this critical interval, additional candidate genes are to
be investigated in the region between TL337MS and
TL195IIMS. Although the mutation causing gPRA in
Schapendoes has not yet been identified, the critical region
for the location of the mutation was reduced to 5.6 Mb. Our
findings for gPRA in the Schapendoes breed constitute an in-
teresting naturally occurring model for RP, the human coun-
terpart of gPRA.
Based on linkage analysis data, we established an indi-
rect DNA test for gPRA in this breed. Nearly 600 dogs with a
mean age of five years have been tested so far. Based on the
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179age of onset of 2-5 years in the Schapendoes breed, affected
dogs among the tested individuals are likely to show initial
gPRA symptoms. All 18 phenotypically affected dogs were
tested as harbouring the linked haplotype in homozygous state,
and all healthy obligatory carriers were typed as being het-
erozygous. The degree of certainty for a test result depends on
the rate of recombination (so far no recombinations were ob-
served) or new mutations. Theoretically small uncalculatable
risks remain for false negative and positive results, respec-
tively. Notwithstanding, the established indirect DNA test fa-
cilitates the eradication of gPRA among Schapendoes. Known
mutation carriers can still produce offspring by selective cross-
ing to dogs with mutation-free haplotypes.
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